Literature DB >> 22424821

Elevated IgG levels against specific bacterial antigens in obese patients with diabetes and in mice with diet-induced obesity and glucose intolerance.

Nadeem Mohammed1, Lihua Tang, Anisa Jahangiri, Willem de Villiers, Erik Eckhardt.   

Abstract

High fat diets increase the risk for insulin resistance by promoting inflammation. The cause of inflammation is unclear, but germfree mouse studies have implicated commensal gut bacteria. We tested whether diet-induced obesity, diabetes, and inflammation are associated with anti-bacterial IgG. Blood from lean and obese healthy volunteers or obese patients with diabetes were analyzed by ELISA for IgG against extracts of potentially pathogenic and pro-biotic strains of Escherichia coli (LF-82 and Nissle), Bacteroides thetaiotaomicron, and Lactobacillus acidophilus, and for circulating tumor necrosis factor α (TNFα). C57Bl/6 mice were fed low- or high-fat diets (10% or 60% kcal from fat) for 10 weeks and tested for anti-bacterial IgG, bodyweight, fasting glucose, and inflammation. Obese diabetic patients had significantly more IgG against extracts of E. coli LF-82 compared with lean controls, whereas IgG against extracts of the other bacteria was unchanged. Circulating TNFα was elevated and correlated with IgG against the LF-82 extract. Mice fed high-fat diets had increased fasting glucose levels, elevated TNFα and neutrophils, and significantly more IgG against the LF-82 extracts. Diabetes in obesity is characterized by increased IgG against specific bacterial antigens. Specific commensal bacteria may mediate inflammatory effects of high-fat diets.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22424821      PMCID: PMC3381856          DOI: 10.1016/j.metabol.2012.02.007

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  18 in total

1.  Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism.

Authors:  Sylvie Rabot; Mathieu Membrez; Aurélia Bruneau; Philippe Gérard; Taoufiq Harach; Mireille Moser; Frederic Raymond; Robert Mansourian; Chieh J Chou
Journal:  FASEB J       Date:  2010-08-19       Impact factor: 5.191

2.  Mechanisms underlying the resistance to diet-induced obesity in germ-free mice.

Authors:  Fredrik Bäckhed; Jill K Manchester; Clay F Semenkovich; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-08       Impact factor: 11.205

3.  Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.

Authors:  Paola Brun; Ignazio Castagliuolo; Vincenza Di Leo; Andrea Buda; Massimo Pinzani; Giorgio Palù; Diego Martines
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-10-05       Impact factor: 4.052

4.  TLR4 links innate immunity and fatty acid-induced insulin resistance.

Authors:  Hang Shi; Maia V Kokoeva; Karen Inouye; Iphigenia Tzameli; Huali Yin; Jeffrey S Flier
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

5.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

6.  Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5.

Authors:  Matam Vijay-Kumar; Jesse D Aitken; Frederic A Carvalho; Tyler C Cullender; Simon Mwangi; Shanthi Srinivasan; Shanthi V Sitaraman; Rob Knight; Ruth E Ley; Andrew T Gewirtz
Journal:  Science       Date:  2010-03-04       Impact factor: 47.728

7.  Chylomicrons promote intestinal absorption of lipopolysaccharides.

Authors:  Sarbani Ghoshal; Jassir Witta; Jian Zhong; Willem de Villiers; Erik Eckhardt
Journal:  J Lipid Res       Date:  2008-09-24       Impact factor: 5.922

8.  Metabolic endotoxemia initiates obesity and insulin resistance.

Authors:  Patrice D Cani; Jacques Amar; Miguel Angel Iglesias; Marjorie Poggi; Claude Knauf; Delphine Bastelica; Audrey M Neyrinck; Francesca Fava; Kieran M Tuohy; Chantal Chabo; Aurélie Waget; Evelyne Delmée; Béatrice Cousin; Thierry Sulpice; Bernard Chamontin; Jean Ferrières; Jean-François Tanti; Glenn R Gibson; Louis Casteilla; Nathalie M Delzenne; Marie Christine Alessi; Rémy Burcelin
Journal:  Diabetes       Date:  2007-04-24       Impact factor: 9.461

9.  High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse.

Authors:  Shengli Ding; Michael M Chi; Brooks P Scull; Rachael Rigby; Nicole M J Schwerbrock; Scott Magness; Christian Jobin; Pauline K Lund
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

10.  Experimental endotoxemia induces adipose inflammation and insulin resistance in humans.

Authors:  Nehal N Mehta; Fiona C McGillicuddy; Paul D Anderson; Christine C Hinkle; Rachana Shah; Leticia Pruscino; Jennifer Tabita-Martinez; Kim F Sellers; Michael R Rickels; Muredach P Reilly
Journal:  Diabetes       Date:  2009-09-30       Impact factor: 9.461

View more
  15 in total

1.  Immune-mediated hookworm clearance and survival of a marine mammal decrease with warmer ocean temperatures.

Authors:  Mauricio Seguel; Felipe Montalva; Diego Perez-Venegas; Josefina Gutiérrez; Hector J Paves; Ananda Müller; Carola Valencia-Soto; Elizabeth Howerth; Victoria Mendiola; Nicole Gottdenker
Journal:  Elife       Date:  2018-11-06       Impact factor: 8.140

Review 2.  B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance.

Authors:  Daniel A Winer; Shawn Winer; Melissa H Y Chng; Lei Shen; Edgar G Engleman
Journal:  Cell Mol Life Sci       Date:  2013-10-15       Impact factor: 9.261

Review 3.  B Lymphocytes and Adipose Tissue Inflammation.

Authors:  Prasad Srikakulapu; Coleen A McNamara
Journal:  Arterioscler Thromb Vasc Biol       Date:  2020-03-05       Impact factor: 8.311

Review 4.  The neurobiology of food intake in an obesogenic environment.

Authors:  Hans-Rudolf Berthoud
Journal:  Proc Nutr Soc       Date:  2012-07-17       Impact factor: 6.297

Review 5.  Methods in microbiome research: Past, present, and future.

Authors:  Emily C Gotschlich; Robert A Colbert; Tejpal Gill
Journal:  Best Pract Res Clin Rheumatol       Date:  2020-04-24       Impact factor: 4.098

6.  Bacterial Translocation and Risk of Liver Cancer in a Finnish Cohort.

Authors:  Baiyu Yang; Jessica L Petrick; Jake E Thistle; Ligia A Pinto; Troy J Kemp; Hao Quang Tran; Andrew T Gewirtz; Tim Waterboer; Veronika Fedirko; Mazda Jenab; Barry I Graubard; Stephanie J Weinstein; Demetrius Albanes; Katherine A McGlynn
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-01-02       Impact factor: 4.254

7.  Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens.

Authors:  Melody Y Zeng; Daniel Cisalpino; Saranyaraajan Varadarajan; Judith Hellman; H Shaw Warren; Marilia Cascalho; Naohiro Inohara; Gabriel Núñez
Journal:  Immunity       Date:  2016-03-02       Impact factor: 31.745

8.  Circulating Biomarkers of Gut Barrier Function: Correlates and Nonresponse to Calcium Supplementation among Colon Adenoma Patients.

Authors:  Baiyu Yang; Roberd M Bostick; Hao Quang Tran; Andrew T Gewirtz; Peter T Campbell; Veronika Fedirko
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-12-16       Impact factor: 4.254

9.  Effects of Supplemental Calcium and Vitamin D on Circulating Biomarkers of Gut Barrier Function in Patients with Colon Adenoma: A Randomized Clinical Trial.

Authors:  Kelly Vermandere; Roberd M Bostick; Hao Q Tran; Andrew T Gewirtz; Elizabeth L Barry; Robin E Rutherford; March E Seabrook; Veronika Fedirko
Journal:  Cancer Prev Res (Phila)       Date:  2020-11-23

Review 10.  Early Life Exposure to Food Contaminants and Social Stress as Risk Factor for Metabolic Disorders Occurrence?-An Overview.

Authors:  Laurence Guzylack-Piriou; Sandrine Ménard
Journal:  Biomolecules       Date:  2021-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.